Scarica l'app Stockscreener
2.55
6.25%
-0.17
Pre-mercato:
2.49
-0.06
-2.35%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Anixa Biosciences Inc Borsa (ANIX) Ultime notizie
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Anixa Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results - Oncodaily
Anixa Biosciences (ANIX) Advances Breast Cancer Vaccine with New Manufacturing Agreement - GuruFocus
Anixa partners with Cytovance for breast cancer vaccine trial - Investing.com
Anixa partners with Cytovance for breast cancer vaccine trial By Investing.com - Investing.com India
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results Cytovance Selected For Cgmp Manufacturing - TradingView
Anixa Biosciences, Inc. (ANIX) Stock Price, News, Quote & History - Yahoo Finance
Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 After Positive Phase 1 Results; Cytovance Selected for cGMP Manufacturing - Barchart
ANIX: Anixa Biosciences Retains 'Buy' Rating with Price Target U - GuruFocus
Anixa Biosciences, Inc. (ANIX) Options Chain - Yahoo! Finance Canada
Anixa Biosciences (NASDAQ:ANIX) Given Buy Rating at D. Boral Capital - MarketBeat
Anixa Biosciences to Present Ovarian Cancer CAR-T Therapy Trial at Gynecologic Oncology Conference - National Today
Anixa Biosciences Advances Cancer Therapy with Lira-cel Trial Update - Intellectia AI
Doctors will get a Phase 1 update on Anixa's ovarian cancer CAR-T - stocktitan.net
Anixa Biosciences, Inc.Common Stock (NQ: ANIX - The Chronicle-Journal
Investment Review: Can Anixa Biosciences Inc keep up with sector leaders2026 Fed Impact & Stock Market Timing Techniques - baoquankhu1.vn
ANIX Stock Price, Quote & Chart | ANIXA BIOSCIENCES INC (NASDAQ:ANIX) - ChartMill
Earnings Recap: Whats the beta of Anixa Biosciences Inc stockPortfolio Performance Report & Technical Pattern Based Buy Signals - baoquankhu1.vn
We're Not Very Worried About Anixa Biosciences' (NASDAQ:ANIX) Cash Burn Rate - Sahm
Anixa Biosciences (NASDAQ:ANIX) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Exclusive: Anixa Biosciences' ovarian cancer drug candidate shows longer survival with no major safety issues - MSN
Anixa Biosciences (NASDAQ:ANIX) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Anixa Biosciences AGM: Shareholders Back Directors as CEO Highlights CAR-T, Vaccine Progress - MarketBeat
Can Anixa Biosciences Inc keep up with sector leadersTrade Risk Assessment & Verified Stock Trade Ideas - baoquankhu1.vn
Anixa Biosciences Featured on Water Tower Research Healthcare Ha - GuruFocus
Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast - PR Newswire
Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast (2026-03-12) - Seeking Alpha
Anixa Biosciences Shareholders Back Board and Compensation - TipRanks
Anixa Biosciences (NASDAQ: ANIX) investors approve directors, pay and auditor - Stock Titan
Anixa Biosciences, Inc. (ANIX) Shareholder/Analyst CallSlideshow (NASDAQ:ANIX) 2026-03-11 - Seeking Alpha
Anixa Biosciences : 2026 Annual Meeting of Shareholders Presentation - marketscreener.com
Anixa Biosciences Inc. Q1 2026 Financial Report: Earnings, Balance Sheet, and Key Disclosures - Minichart
Anixa receives Korean patent allowance for breast cancer vaccine By Investing.com - Investing.com Canada
Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology - irw-press.com
Anixa Biosciences Inc reports results for the quarter ended January 31Earnings Summary - TradingView
ANIXA BIOSCIENCES ($ANIX) Releases Q1 2026 Earnings - Quiver Quantitative
Anixa Biosciences (NASDAQ:ANIX) Posts Earnings Results, Beats Expectations By $0.01 EPS - MarketBeat
Anixa 10-Q: $0 Revenue, $(0.08) EPS for Q3 (Jan 31, 2026) - TradingView
Anixa Biosciences (NASDAQ: ANIX) narrows loss and advances cancer vaccine and CAR-T programs - Stock Titan
Anixa Biosciences, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2026 - marketscreener.com
Anixa Biosciences Receives Notice of Allowance from Korean Minis - GuruFocus
Anixa Biosciences (ANIX) Secures Patent in South Korea for Breas - GuruFocus
Anixa receives Korean patent allowance for breast cancer vaccine - Investing.com
Anixa Biosciences (NASDAQ:ANIX) Upgraded to Hold at Wall Street Zen - MarketBeat
Anixa Biosciences Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
ANIX SEC FilingsAnixa Biosciences Inc 10-K, 10-Q, 8-K Forms - Stock Titan
ANIX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Anixa Biosciences (ANIX) to Release Earnings on Tuesday - MarketBeat
Anixa Biosciences to host 2026 annual meeting of stockholders and provide corporate update highlighting recent clinical and regulatory progress - marketscreener.com
Anixa Biosciences To Host 2026 Annual Meeting Of Stockholders And Provide Corporate Update Highlighting Recent Clinical And Regulatory Progress - TradingView
Anixa to outline ovarian CAR-T survival, breast cancer vaccine data - Stock Titan
Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress - morningstar.com
Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Recommendation of "Hold" by Analysts - MarketBeat
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):